High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure

Summary

To demonstrate the effectiveness and safety of nocturnal ventilation with oxygen (HFT - high-flow-therapy) for the treatment of CSA in patients with HFrEF compared to placebo (patient will breathe ambient air via nasal cannula that is not connected to the high-flow-device).

Timeline

Start

2017-02-02

Primary completion

2018-03-27

Completion

2018-03-27

Drugs

Indications